These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6316374)

  • 1. Effects of mu- and kappa-opioid receptor agonists on urinary output in mice.
    Rathbun RC; Kattau RW; Leander JD
    Pharmacol Biochem Behav; 1983 Nov; 19(5):863-6. PubMed ID: 6316374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further study of kappa opioids on increased urination.
    Leander JD
    J Pharmacol Exp Ther; 1983 Oct; 227(1):35-41. PubMed ID: 6137557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A kappa opioid effect: increased urination in the rat.
    Leander JD
    J Pharmacol Exp Ther; 1983 Jan; 224(1):89-94. PubMed ID: 6294284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delineation of mu-antagonist, partial kappa agonist and non-opioid agonist activity of cyclazocine using urinary output of rats.
    Leander JD
    Pharmacol Biochem Behav; 1987 Apr; 26(4):705-7. PubMed ID: 3037567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential cross-tolerance to mu and kappa opioid agonists in morphine-tolerant rats responding under a schedule of food presentation.
    Picker MJ; Negus SS; Powell KR
    Psychopharmacology (Berl); 1991; 103(1):129-35. PubMed ID: 1848712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kappa opioid agonists and antagonists: effects on drinking and urinary output.
    Leander JD
    Appetite; 1984 Mar; 5(1):7-14. PubMed ID: 6091543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist and antagonist activity of kappa opioids in the squirrel monkey: I. Antinociception and urine output.
    Craft RM; Dykstra LA
    J Pharmacol Exp Ther; 1992 Jan; 260(1):327-33. PubMed ID: 1309876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kappa-opiates and urination: pharmacological evidence for an endogenous role of the kappa-opiate receptor in fluid and electrolyte balance.
    Huidobro-Toro JP; Parada S
    Eur J Pharmacol; 1984 Dec; 107(1):1-10. PubMed ID: 6098480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential cross-tolerance to opioid agonists in morphine-tolerant pigeons responding under a schedule of food presentation.
    Craft RM; Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1989 May; 249(2):386-93. PubMed ID: 2542528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bremazocine: a potent, long-acting opiate kappa-agonist.
    Römer D; Büscher H; Hill RC; Maurer R; Petcher TJ; Welle HB; Bakel HC; Akkerman AM
    Life Sci; 1980 Sep; 27(11):971-8. PubMed ID: 6253759
    [No Abstract]   [Full Text] [Related]  

  • 13. The kappa opioid receptor and food intake.
    Morley JE; Levine AS; Kneip J; Grace M; Zeugner H; Shearman GT
    Eur J Pharmacol; 1985 May; 112(1):17-25. PubMed ID: 2990965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of mu and kappa opioid receptor agonists on rat plasma corticosterone levels.
    Hayes AG; Stewart BR
    Eur J Pharmacol; 1985 Oct; 116(1-2):75-9. PubMed ID: 2996912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dose-ratio comparison of mu and kappa agonists in formalin and thermal pain.
    Abbott FV; Franklin KB; Libman RB
    Life Sci; 1986 Nov; 39(21):2017-24. PubMed ID: 3023775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of mu- and kappa-opioid agonists on the electroconvulsive seizure threshold in mice and antagonism by naloxone and MR 2266.
    Frey HH
    Pharmacol Toxicol; 1988 Mar; 62(3):150-4. PubMed ID: 2836842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kappa agonist-induced diuresis: evidence for stereoselectivity, strain differences, independence of hydration variables and a result of decreased plasma vasopressin levels.
    Leander JD; Hart JC; Zerbe RL
    J Pharmacol Exp Ther; 1987 Jul; 242(1):33-9. PubMed ID: 3039112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. U-50,488, a selective kappa opioid agonist: comparison to other reputed kappa agonists.
    Von Voigtlander PF; Lewis RA
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):467-70. PubMed ID: 6298890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between mu and kappa opioid agonists in the rat drug discrimination procedure.
    Negus SS; Picker MJ; Dykstra LA
    Psychopharmacology (Berl); 1990; 102(4):465-73. PubMed ID: 1965748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation between mu and kappa receptor-mediated effects in opioid drug discrimination: apparent pA2 analysis.
    Bertalmio AJ; Woods JH
    J Pharmacol Exp Ther; 1987 Nov; 243(2):591-7. PubMed ID: 2824753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.